Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
AstraZeneca's strong earnings boost FTSE 100, while other companies show mixed results.
AstraZeneca reported strong first-half 2025 results, with revenue up 9.5% and pretax profit up 26%.
Barclays also boosted earnings and announced a £1bn share buyback.
However, Greggs saw a 14% drop in profit despite higher sales.
The FTSE 100 index rose 0.53% on Tuesday, buoyed by positive earnings reports and the AstraZeneca boost.
The healthcare sector saw mixed results, with AstraZeneca leading gains while other companies like Novo Nordisk underperformed.
12 Articles
Las fuertes ganancias de AstraZeneca impulsan a FTSE 100, mientras que otras compañías muestran resultados mixtos.